Old Web
English
Sign In
Acemap
>
Paper
>
1204P Cost-benefit analysis of ALK diagnosis in patients with non-small cell lung cancer in Spain
1204P Cost-benefit analysis of ALK diagnosis in patients with non-small cell lung cancer in Spain
2021
A. L. Ortega Granados
F. Rojo Todo
R. Alvarez Alvarez
M. Majem Tarruella
L. Ruiz de Alda Iparraguirre
J.F. García Verdes-Montenegro
R. Gordo Flores
A. González Domínguez
Y. Ivanova Markova
R. Sánchez San Cristóbal
Keywords:
Cost–benefit analysis
Oncology
non small cell
in patient
Internal medicine
Medicine
Lung cancer
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]